 NewAmsterdam Pharma Company N.V.NAMS | $774k24.4k shares | SellJan 28, 2026 | $1.0M32.6k shares | $31.80 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $621k57k shares | Grant / ExerciseJan 28, 2026 | $355.5K32.6k shares | $10.90 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $794k24.4k shares | SellJan 27, 2026 | $1.3M39.8k shares | $32.62 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $699k64.2k shares | Grant / ExerciseJan 27, 2026 | $434.0K39.8k shares | $10.90 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $808k24.7k shares | SellJan 26, 2026 | $1.1M34.1k shares | $32.77 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $640k58.8k shares | Grant / ExerciseJan 26, 2026 | $375.0K34.4k shares | $10.90 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $815k24.4k shares | SellJan 26, 2026 | $10.3K309 shares | $33.45 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $1.2M37.1k shares | SellJan 23, 2026 | $849.5K25.4k shares | $33.44 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $837k24.4k shares | SellJan 23, 2026 | $438.8K12.8k shares | $34.37 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $682k62.5k shares | Grant / ExerciseJan 23, 2026 | $416.1K38.2k shares | $10.90 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $1.9M53.5k shares | Grant / ExerciseJan 7, 2026 | $1.9M53.5k shares | $35.45 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | --24.4k shares | Grant / ExerciseJan 7, 2026 | Disclosure amount unavailable12k shares | -- | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $411k12.4k shares | SellJan 5, 2026 | $88.0K2.6k shares | $33.25 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $530k15k shares | SellDec 26, 2025 | $1.5M43.9k shares | $35.30 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $539k53.9k shares | Grant / ExerciseDec 26, 2025 | $388.7K38.9k shares | $10.00 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $642k58.9k shares | Grant / ExerciseDec 26, 2025 | $54.5K5k shares | $10.90 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $535k15k shares | SellDec 24, 2025 | $928.1K26k shares | $35.68 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $410k41k shares | Grant / ExerciseDec 24, 2025 | $260.1K26k shares | $10.00 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $543k15k shares | SellDec 23, 2025 | $2.7M75.1k shares | $36.21 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $901k90.1k shares | Grant / ExerciseDec 23, 2025 | $751.2K75.1k shares | $10.00 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $392k15k shares | SellSep 9, 2025 | $2.5M96.9k shares | $26.11 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $1.6M165k shares | Grant / ExerciseSep 9, 2025 | $1.5M150k shares | $10.00 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $2.8M111.9k shares | SellSep 9, 2025 | $1.3M53.1k shares | $25.31 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $376k15k shares | SellSep 3, 2025 | $453.5K18.1k shares | $25.09 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | --18.1k shares | Grant / ExerciseSep 2, 2025 | Disclosure amount unavailable18.1k shares | -- | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $373k15k shares | SellAug 25, 2025 | $205.6K8.3k shares | $24.86 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | --8.3k shares | Grant / ExerciseMar 26, 2025 | Disclosure amount unavailable8.3k shares | -- | -- |
| NewAmsterdam Pharma Company N.V.NAMS | --8.3k shares | Grant / ExerciseMar 26, 2025 | Disclosure amount unavailable8.3k shares | -- | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $306k15k shares | SellMar 4, 2025 | $3.1M150k shares | $20.37 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | --18.1k shares | Grant / ExerciseMar 4, 2025 | Disclosure amount unavailable150k shares | -- | -- |
| NewAmsterdam Pharma Company N.V.NAMS | --15k shares | Grant / ExerciseJan 7, 2025 | Disclosure amount unavailable15k shares | -- | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $2.1M80k shares | Grant / ExerciseJan 2, 2025 | $2.1M80k shares | $25.96 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | $045k shares | SellOct 1, 2024 | $707.4K45k shares | $15.72 | -- |
| NewAmsterdam Pharma Company N.V.NAMS | --45k shares | Grant / ExerciseSep 27, 2024 | Disclosure amount unavailable45k shares | -- | -- |